Wealthcare Advisory Partners LLC Sage Therapeutics, Inc. Transaction History

Wealthcare Advisory Partners LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$54.88 - $79.29 $16,464 - $23,787	-300 Closed	0 $0
Q1 2021 Apr 30, 2021	BUY	$70.65 - $96.76 $21,195 - $29,028	300 New	300 $22,000
Q2 2020 Jul 29, 2020	SELL	$25.95 - $43.15 $7,785 - $12,945	-300 Closed	0 $0
Q4 2019 Jan 29, 2020	BUY	$60.18 - $154.77 $3,009 - $7,738	50 Added 20.0%	300 $22,000
Q3 2019 Oct 17, 2019	BUY	$140.29 - $189.96 $21,043 - $28,494	150 Added 150.0%	250 $35,000
Q2 2019 Jul 30, 2019	BUY	$157.85 - $183.09 $15,785 - $18,309	100 New	100 $18,000

218

48.2M

854K

195K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $395M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Wealthcare Advisory Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Wealthcare Advisory Partners LLC with notifications on news.